4Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030[ J]. Diabetes Care,2004,27 (5) : 1047-1053. 被引量：1
5Kleinman JC, Donahue liP, Harris MI, et al. Mortality among dia-betics in a national sample ~ J ]. Am J Epidemiol, 1988,128 (2) : 389-401. 被引量：1
7Hirsch IB, Bmwnlee M. Should minimal blood glucose variability become the gold standard of glycemie control.'? [ J ]. J Diabetes Complications ,2005,19(3 ) : 178-181. 被引量：1
8He YL, Foteinos G, Neelakantham S, et al. Differential effects of vildagliptin and glimcpiridc on glucose fluctuations in patients with type 2 diabetes mcllitus assessed using continuous glueesc monito- ring [ J 1. Diabetes Obcs Metab ,2013,15 (12) : 1111-1119. 被引量：1
9Zhang NB, Huang ZG, Cui WD, et al. Effects of puerarin on expression of cardiac Smad3 and Smad7 mRNA in spontaneously hypertensive rat [ J 1. J Ethnopharmacology ,2011,138 (3) :737 -740. 被引量：1
10Zhang W, Liu CQ, Wang PW, et al. Puerarin improves insulin resistance and modulates adipokine expression in rats fed a high- fat diet [ J]. Eur J Pharmaco1,2010,649 ( 1/3 ) :398-402. 被引量：1
